TOVX Theriva Biologics, Inc.

$0.25 +0.50%

Updated 16 d ago

Healthcare · Pharmaceutical Preparations

Theriva Biologics, Inc. (TOVX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $12 million. Shares last traded at $0.25, 71.3% below their 52-week high. Over the past year the stock is down 35.3%. Revenue declined 100.0% year over year.

Market Cap

$12M

Shares Out

45.9M

EPS (TTM)

$-7.19

P/E Ratio

—

P/S Ratio

—

P/B Ratio

0.95

Dividend / Share

—

Dividend Yield

—

52-Week High

$0.88

52-Week Low

$0.17

Volume

4,001

Avg Vol (3m)

171,767.889

Performance

-0.75%

+11.68%

-2.88%

+37.53%

YTD

-1.44%

-35.26%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. TOVX split history →

Technicals

RSI (14)

59.56

SMA (50)

$0.23

SMA (200)

$0.24

Price vs SMA50

+7.89%

Price vs SMA200

+6.38%

ATR (14)

$0.01

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$0M

Net Income

$-12M

Gross Margin

—

Operating Margin

—

Net Margin

—

Return on Equity

-95.3%

Return on Assets

-33.3%

Current Ratio

1.13

Debt / Equity

0.14

Revenue Growth (YoY)

-100.0%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.12	2026-08-11
Q1 2026	$-0.05	2026-05-05
FY 2025	$-2.08	2026-03-12
Q3 2025	$-3.38	2025-11-12
Q2 2026	$-3.64	2026-08-11
Q1 2026	$-1.55	2026-05-05

Full earnings history →

Pharmaceutical Preparations peers

TOVX vs 14 industry peers (Pharmaceutical Preparations), by market cap. Updated 16 d ago

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%
REGN	Regeneron Pharmaceuticals	$87.2B	20.15	5.61	27.9%	-1.02%
TEVA	Teva Pharmaceutical Industries Ltd	$42.6B	60.41	2.46	4.1%	-2.32%
ALNY	Alnylam Pharmaceuticals	$35.4B	43.77	9.52	21.8%	-1.10%
ZTS	Zoetis	$31.5B	12.05	3.31	27.5%	+0.16%
RPRX	Royalty Pharma Plc	$28.2B	34.56	11.11	32.1%	+1.24%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.